485 related articles for article (PubMed ID: 29569957)
1. Protein tyrosine phosphatase 1B inactivation limits aging-associated heart failure in mice.
Besnier M; Coquerel D; Favre J; Dumesnil A; Guerrot D; Remy-Jouet I; Mulder P; Djerada Z; Tamion F; Richard V; Ouvrard-Pascaud A
Am J Physiol Heart Circ Physiol; 2018 Jun; 314(6):H1279-H1288. PubMed ID: 29569957
[TBL] [Abstract][Full Text] [Related]
2. Endothelial deletion of protein tyrosine phosphatase-1B protects against pressure overload-induced heart failure in mice.
Gogiraju R; Schroeter MR; Bochenek ML; Hubert A; Münzel T; Hasenfuss G; Schäfer K
Cardiovasc Res; 2016 Aug; 111(3):204-16. PubMed ID: 27207947
[TBL] [Abstract][Full Text] [Related]
3. Enhanced angiogenesis and increased cardiac perfusion after myocardial infarction in protein tyrosine phosphatase 1B-deficient mice.
Besnier M; Galaup A; Nicol L; Henry JP; Coquerel D; Gueret A; Mulder P; Brakenhielm E; Thuillez C; Germain S; Richard V; Ouvrard-Pascaud A
FASEB J; 2014 Aug; 28(8):3351-61. PubMed ID: 24760754
[TBL] [Abstract][Full Text] [Related]
4. Selective Vascular Endothelial Protection Reduces Cardiac Dysfunction in Chronic Heart Failure.
Maupoint J; Besnier M; Gomez E; Bouhzam N; Henry JP; Boyer O; Nicol L; Mulder P; Martinet J; Richard V
Circ Heart Fail; 2016 Apr; 9(4):e002895. PubMed ID: 27059805
[TBL] [Abstract][Full Text] [Related]
5. Reduction of heart failure by pharmacological inhibition or gene deletion of protein tyrosine phosphatase 1B.
Gomez E; Vercauteren M; Kurtz B; Ouvrard-Pascaud A; Mulder P; Henry JP; Besnier M; Waget A; Hooft Van Huijsduijnen R; Tremblay ML; Burcelin R; Thuillez C; Richard V
J Mol Cell Cardiol; 2012 Jun; 52(6):1257-64. PubMed ID: 22446161
[TBL] [Abstract][Full Text] [Related]
6. Ubiquitin ligase
Snyder LB; Lai Y; Doviak H; Freeburg LA; Laney VK; Moore A; Zellars KN; Matesic LE; Spinale FG
Am J Physiol Heart Circ Physiol; 2021 Nov; 321(5):H976-H984. PubMed ID: 34559578
[TBL] [Abstract][Full Text] [Related]
7. Gene deletion of protein tyrosine phosphatase 1B protects against sepsis-induced cardiovascular dysfunction and mortality.
Coquerel D; Neviere R; Delile E; Mulder P; Marechal X; Montaigne D; Renet S; Remy-Jouet I; Gomez E; Henry JP; do Rego JC; Richard V; Tamion F
Arterioscler Thromb Vasc Biol; 2014 May; 34(5):1032-44. PubMed ID: 24578383
[TBL] [Abstract][Full Text] [Related]
8. The ubiquitin ligase WWP1 contributes to shifts in matrix proteolytic profiles and a myocardial aging phenotype with diastolic heart.
Matesic LE; Freeburg LA; Snyder LB; Duncan LA; Moore A; Perreault PE; Zellars KN; Goldsmith EC; Spinale FG
Am J Physiol Heart Circ Physiol; 2020 Oct; 319(4):H765-H774. PubMed ID: 32822210
[TBL] [Abstract][Full Text] [Related]
9. Cardiomyocyte dimethylarginine dimethylaminohydrolase-1 (DDAH1) plays an important role in attenuating ventricular hypertrophy and dysfunction.
Xu X; Zhang P; Kwak D; Fassett J; Yue W; Atzler D; Hu X; Liu X; Wang H; Lu Z; Guo H; Schwedhelm E; Böger RH; Chen P; Chen Y
Basic Res Cardiol; 2017 Aug; 112(5):55. PubMed ID: 28819685
[TBL] [Abstract][Full Text] [Related]
10. Myocardial overexpression of TIMP3 after myocardial infarction exerts beneficial effects by promoting angiogenesis and suppressing early proteolysis.
Takawale A; Zhang P; Azad A; Wang W; Wang X; Murray AG; Kassiri Z
Am J Physiol Heart Circ Physiol; 2017 Aug; 313(2):H224-H236. PubMed ID: 28550172
[TBL] [Abstract][Full Text] [Related]
11. Intercellular Adhesion Molecule 1 Regulates Left Ventricular Leukocyte Infiltration, Cardiac Remodeling, and Function in Pressure Overload-Induced Heart Failure.
Salvador AM; Nevers T; Velázquez F; Aronovitz M; Wang B; Abadía Molina A; Jaffe IZ; Karas RH; Blanton RM; Alcaide P
J Am Heart Assoc; 2016 Mar; 5(3):e003126. PubMed ID: 27068635
[TBL] [Abstract][Full Text] [Related]
12. Interferon-γ ablation exacerbates myocardial hypertrophy in diastolic heart failure.
Garcia AG; Wilson RM; Heo J; Murthy NR; Baid S; Ouchi N; Sam F
Am J Physiol Heart Circ Physiol; 2012 Sep; 303(5):H587-96. PubMed ID: 22730392
[TBL] [Abstract][Full Text] [Related]
13. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
Poulsen SH
Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125
[TBL] [Abstract][Full Text] [Related]
14. Chronic urocortin 2 administration improves cardiac function and ameliorates cardiac remodeling after experimental myocardial infarction.
Ellmers LJ; Scott NJ; Cameron VA; Richards AM; Rademaker MT
J Cardiovasc Pharmacol; 2015 Mar; 65(3):269-75. PubMed ID: 25658462
[TBL] [Abstract][Full Text] [Related]
15. Concentric left ventricular remodeling in endothelial nitric oxide synthase knockout mice by chronic pressure overload.
Ruetten H; Dimmeler S; Gehring D; Ihling C; Zeiher AM
Cardiovasc Res; 2005 Jun; 66(3):444-53. PubMed ID: 15914109
[TBL] [Abstract][Full Text] [Related]
16. Beta-blocker improves survival, left ventricular function, and myocardial remodeling in hypertensive rats with diastolic heart failure.
Kobayashi M; Machida N; Mitsuishi M; Yamane Y
Am J Hypertens; 2004 Dec; 17(12 Pt 1):1112-9. PubMed ID: 15607617
[TBL] [Abstract][Full Text] [Related]
17. Endothelial nitric oxide synthase limits left ventricular remodeling after myocardial infarction in mice.
Scherrer-Crosbie M; Ullrich R; Bloch KD; Nakajima H; Nasseri B; Aretz HT; Lindsey ML; Vançon AC; Huang PL; Lee RT; Zapol WM; Picard MH
Circulation; 2001 Sep; 104(11):1286-91. PubMed ID: 11551881
[TBL] [Abstract][Full Text] [Related]
18. Increased Protein Tyrosine Phosphatase 1B (PTP1B) Activity and Cardiac Insulin Resistance Precede Mitochondrial and Contractile Dysfunction in Pressure-Overloaded Hearts.
Nguyen TD; Schwarzer M; Schrepper A; Amorim PA; Blum D; Hain C; Faerber G; Haendeler J; Altschmied J; Doenst T
J Am Heart Assoc; 2018 Jun; 7(13):. PubMed ID: 29929988
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin type 2 receptor stimulation ameliorates left ventricular fibrosis and dysfunction via regulation of tissue inhibitor of matrix metalloproteinase 1/matrix metalloproteinase 9 axis and transforming growth factor β1 in the rat heart.
Lauer D; Slavic S; Sommerfeld M; Thöne-Reineke C; Sharkovska Y; Hallberg A; Dahlöf B; Kintscher U; Unger T; Steckelings UM; Kaschina E
Hypertension; 2014 Mar; 63(3):e60-7. PubMed ID: 24379181
[TBL] [Abstract][Full Text] [Related]
20. Deriving a cardiac ageing signature to reveal MMP-9-dependent inflammatory signalling in senescence.
Ma Y; Chiao YA; Clark R; Flynn ER; Yabluchanskiy A; Ghasemi O; Zouein F; Lindsey ML; Jin YF
Cardiovasc Res; 2015 Jun; 106(3):421-31. PubMed ID: 25883218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
